BioSpace News Archive

New Expert Panel of Advisors to Shape Nationwide Course of Action for Supporting Female Providers in Aesthetics

Full-year 2018 sales growth of 11.6 percent; organic sales growth of 7.3 percent

Gains new global defense and public-safety customers, and new portfolio of proprietary medical products

Validation study to assess approximately 5,000 patients with participation from a multi-center group of leading U.S. investigators

Company enrolls first patients in feasibility studies for chronic back pain and wrist osteoarthritis, setting clinical development focus on orthopedic indications

-- Expands Potential Serviceable Market to Include Companies Requiring Certification

The Mesothelioma Compensation Center is the best branded source in the nation for the very best possible financial compensation for any type of power or energy worker with mesothelioma or asbestos exposure lung cancer.

Still early in development of the multiple-patented AmnioBed™, its innovative NICU incubator system, Amnion Life, looks to improve infant health while reducing the mortality, morbidity, and length of stay in the neonatal intensive care unit (NICU) for extreme preterm infants who average 110 days in the NICU

The global sickle cell disease treatment market research report by Technavio predicts the market to post a CAGR of more than 11% during the period 2019-2023.

Company’s flagship product, FidoCure, provides dogs with latest scientific advances in cancer care